3 years ago

Fate and removal of selected antibiotics in an osmotic membrane bioreactor

Fate and removal of selected antibiotics in an osmotic membrane bioreactor
The fate and removal behavior of 12 antibiotics from 5 classes were investigated in an osmotic membrane bioreactor (OMBR), along with their effects on the system performance. High overall removal of all the antibiotics (77.7–99.8%) was observed, resulting from their rejection by the forward osmosis membrane (>90%). Biodegradation (ranging from 16.6% to 94.4%) was a significant removal pathway for all the antibiotics except ofloxacin, ciprofloxacin and roxithromycin. Sulfathiazole, enrofloxacin, and chlortetracycline showed the highest removal via biodegradation at 94.4%, 90.2%, and 78.9% respectively, followed by trimethoprim (68.2%), lomefloxacin (57.1%) and norfloxacin (53.2%). Sorption contributed to varying extent to their removal (at 2.0–30.1%); the highest was observed for ofloxacin and roxithromycin. No evident change was observed in the pollutant removal performance of the bioreactor even after 40 days of continuous exposure to these antibiotics (at 500 ng/L), with the overall TOC and NH4 +-N removal maintained >98% and >97%, respectively.

Publisher URL: www.sciencedirect.com/science

DOI: S1385894717317321

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.